NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Two-third of Indians have COVID-19 antibodies: ICMR serosurvey
    Two-third of Indians have COVID-19 antibodies: ICMR serosurvey
    1/6
    India 2 min read

    Two-third of Indians have COVID-19 antibodies: ICMR serosurvey

    By Pratyush Deep Kotoky
    Jul 20, 2021
    11:25 pm
    Two-third of Indians have COVID-19 antibodies: ICMR serosurvey
    The ICMR found 85% of the surveyed healthcare workers and 50% of children have antibodies against COVID-19.

    Around 40 crore Indians are still vulnerable to COVID-19 infections, according to India's fourth national serological survey. The survey found that 67.6% of Indians above the age of six have antibodies against SARS-CoV-2, the virus causing COVID-19. Notably, this is a steep increase from the results of the third serosurvey, conducted in December-January, which found antibodies in 21% of the population above age 10.

    2/6

    10% healthcare workers yet to be vaccinated: Government

    The fourth serosurvey was conducted by the Indian Council for Medical Research (ICMR) across 70 districts in 21 states in June-July. As per the ICMR, the survey included 36,227 people, out of which, 7,252 are healthcare workers. The ICMR found 85% of the surveyed healthcare workers (HCWs) had antibodies against coronavirus, while one-tenth of HCWs were still unvaccinated.

    3/6

    There is hope, but no room for complacency: ICMR

    While announcing the results of the serosurvey, the government also warned people against the laxity in following COVID-19 appropriate behavior as about one-third of Indians do not have COVID-19 antibodies. ICMR chief Dr. Balram Bhargava said, "The implications of the fourth serosurvey clearly show there is a ray of hope, but there is no room for complacency. We must maintain COVID-appropriate behavior."

    4/6

    50% of children aged 6-17 years have antibodies

    The survey also found that over 50% of children between the age of six to 17 have antibodies against the SARS-CoV-2 virus. The survey found 57.2% seroprevalence in the age group of six-nine years. In the age group of 10-17 years, seroprevalence was 61.6%. Similarly in the age group of 18-44 years and 45-60 years, it was 66.7% and 77.6%, respectively.

    5/6

    Seroprevalence higher among vaccinated people, survey finds

    Stating that there is no difference in seroprevalence in males and females, the ICMR said COVID-19 antibodies were found in 62.3% of unvaccinated people. Among those who had one dose of the vaccine, seroprevalence was 81%. However, among those who had both doses of vaccine, antibodies were detected in 89.8% of people. The ICMR stressed the need to accelerate vaccination among vulnerable groups.

    6/6

    Laxity in preventive behavior cause of concern

    While the government and health experts have warned against an "imminent" third wave of infections, people's laxity in preventive behavior has become a cause of concern. On Monday, the ICMR urged people to avoid social, religious, political gatherings as well as unnecessary travel. Recently, PM Narendra Modi also asked people to follow COVID-19 protocols to stop the spread of the virus.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Indian Council of Medical Research (ICMR)
    COVID-19 Vaccine
    Serological Survey

    Indian Council of Medical Research (ICMR)

    80% post-vaccination infections due to Delta variant, says ICMR study Vaccine
    Delta variant behind majority of 'breakthrough' infections: Study SARS-CoV-2
    Hetero seeks Emergency Use Authorization for Molnupiravir in India Drugs Controller General of India
    COVID-19: Delta Plus variant has spread to 12 Indian states India

    COVID-19 Vaccine

    No sign of Pfizer, Moderna vaccines in breast milk: Study Pfizer
    Coronavirus: 4 vaccines in human trial stage, government tells Parliament Ministry of Health and Family Welfare
    India offered 7.5mn doses of Moderna vaccine under COVAX program Drugs Controller General of India
    Get jabbed, become 'Baahubali': PM Modi Narendra Modi

    Serological Survey

    COVID-19: 4th serosurvey to focus on kids, rural areas Coronavirus
    Half of Delhi has antibodies against COVID-19, finds serological survey Satyendar Jain
    7.4 crore Indians exposed to coronavirus till August: ICMR serosurvey India
    1 in 4 exposed to COVID-19 in Delhi: Sero-prevalence survey Delhi High Court
    Next News Article

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023